HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IDL Lipoproteins (Lipoprotein, IDL)

A mixture of very-low-density lipoproteins (VLDL), particularly the triglyceride-poor VLDL, with slow diffuse electrophoretic mobilities in the beta and alpha2 regions which are similar to that of beta-lipoproteins (LDL) or alpha-lipoproteins (HDL). They can be intermediate (remnant) lipoproteins in the de-lipidation process, or remnants of mutant CHYLOMICRONS and VERY-LOW-DENSITY LIPOPROTEINS which cannot be metabolized completely as seen in FAMILIAL DYSBETALIPOPROTEINEMIA.
Also Known As:
Lipoprotein, IDL; Lipoproteins, IDL; Broad-beta Lipoproteins; Floating beta-Lipoproteins; Intermediate Density Lipoproteins; Intermediate-Density Lipoproteins; Lipoproteins, Intermediate Density; alpha2-VLDL; alpha2-VLDL Lipoprotein; beta-VLDL; beta-VLDL Lipoproteins; Broad beta Lipoprotein; Broad beta Lipoproteins; Density Lipoprotein, Intermediate; Floating beta Lipoprotein; Floating beta Lipoproteins; IDL Lipoprotein; Lipoprotein, Broad-beta; Lipoprotein, Intermediate Density; Lipoprotein, Intermediate-Density; Lipoprotein, alpha2-VLDL; Lipoprotein, alpha2-Very-Low-Density; Lipoprotein, beta-VLDL; Lipoprotein, beta-Very-Low-Density; Lipoproteins, Broad-beta; Lipoproteins, Intermediate-Density; Lipoproteins, alpha2-Very-Low-Density; Lipoproteins, beta-VLDL; Lipoproteins, beta-Very-Low-Density; alpha2 VLDL; alpha2 VLDL Lipoprotein; alpha2 Very Low Density Lipoprotein; alpha2 Very Low Density Lipoproteins; beta VLDL; beta VLDL Lipoprotein; beta VLDL Lipoproteins; beta Very Low Density Lipoprotein; beta Very Low Density Lipoproteins; beta-Lipoprotein, Floating; beta-Lipoproteins, Floating; Broad-beta Lipoprotein; Floating beta-Lipoprotein; Intermediate Density Lipoprotein; Intermediate-Density Lipoprotein; alpha2-Very-Low-Density Lipoprotein; alpha2-Very-Low-Density Lipoproteins; beta-VLDL Lipoprotein; beta-Very-Low-Density Lipoprotein; beta-Very-Low-Density Lipoproteins
Networked: 301 relevant articles (10 outcomes, 25 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Vaziri, Nosratola D: 5 articles (01/2016 - 09/2010)
2. Hirowatari, Yuji: 3 articles (01/2021 - 10/2013)
3. Manita, Daisuke: 3 articles (01/2021 - 10/2013)
4. Yoshida, Hiroshi: 3 articles (01/2021 - 10/2013)
5. Nishizawa, Yoshiki: 3 articles (12/2009 - 01/2002)
6. Shoji, Tetsuo: 3 articles (12/2009 - 01/2002)
7. Girona, Josefa: 2 articles (08/2021 - 11/2015)
8. Ito, Kumie: 2 articles (01/2021 - 10/2013)
9. Sato, Ryo: 2 articles (01/2021 - 10/2013)
10. Saku, Keijiro: 2 articles (11/2019 - 12/2009)

Related Diseases

1. Hypercholesterolemia
2. Hypertriglyceridemia
3. Hyperlipoproteinemia Type III (Broad Beta Disease)
4. Coronary Artery Disease (Coronary Atherosclerosis)
5. Chronic Kidney Failure (Chronic Renal Failure)

Related Drugs and Biologics

1. oxidized low density lipoprotein
2. Cholesterol
3. Lipoproteins (Lipoprotein)
4. LDL Lipoproteins (beta Lipoproteins)
5. VLDL Lipoproteins
6. Lipids
7. IDL Lipoproteins (Lipoprotein, IDL)
8. HDL Lipoproteins
9. Chylomicrons
10. Chylomicron Remnants

Related Therapies and Procedures

1. Plasmapheresis
2. Renal Dialysis (Hemodialysis)
3. Therapeutics
4. Diet Therapy (Therapy, Diet)
5. Blood Component Removal (Apheresis)